Company Celsus Therapeutics PLC (ADR) Nasdaq
Equities
US15119A2024
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-31 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 22-11-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 11-28 |
Director/Board Member | 68 | 18-01-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 13,234,315,298 | 13,101,972,145 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.com![address Celsus Therapeutics PLC (ADR)](https://cdn.zonebourse.com/static/address/15688915.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |